Volume 15 Issue 2 - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Volume 15 Issue 2

Introducing a New Era in HPLC

Fraser McLeod, Vice President of QA/QC for Waters Corporation, explains how Waters's next-generation Alliance™ iS HPLC System will revolutionise productivity and eff...

3 July 2023 Volume 15 Issue 2 drugs | HPLC system

Continue Reading →

Volume 15 Issue 2

IPI Speaks with PharmaLex’s Local Affiliate Services Lead on the Rapidly Changing Global Market

Q: Can we start with some insights as to why the Local Affiliate Services solution was established and what its overarching objectives are? A: There is rising dem...

3 July 2023 Volume 15 Issue 2 Affiliate | compliance

Continue Reading →

Volume 15 Issue 2

The Four Trends Set to Disrupt Highly Regulated Industries in 2023

Bob Tilling, VP Global Sales at Kallik identifies four trends set to disrupt manufacturers in highly regulated industries in 2023: the industrial metaverse, the need...

3 July 2023 Volume 15 Issue 2 cybersecurity | data centricity

Continue Reading →

Volume 15 Issue 2

Vaccine Regulation in India

Vaccines are the most important health intervention. Vaccination stimulates the immune system to identify and battle invaders such as viruses or bacteria. A vaccinat...

3 July 2023 Volume 15 Issue 2 bacteria | effectiveness

Continue Reading →

Volume 15 Issue 2

Serving the 0.05% of Patients Living with a Rare Disease

Increasing adoption of digital trials and data-driven commercial strategies has laid the foundations for improved pinpointing of treatments and speedier diagnoses. ...

3 July 2023 Volume 15 Issue 2 adoption | clinical data

Continue Reading →

Volume 15 Issue 2

Unlocking the Potential of Drug Discovery Labs with Automation

Trying to achieve more without increasing costs, sacrificing quality, or slowing down growth is a constant mission for any expanding business or industry – but it is...

3 July 2023 Volume 15 Issue 2 achieve | automation

Continue Reading →

Volume 15 Issue 2

How to Harness the Benefits of Inhalation When Re-formulating Biologics

The biologics market is growing rapidly and is on track to be worth $719.14 bn by 2030, up from $366.6 bn in 2021.¹ This growth is being driven primarily by the risi...

3 July 2023 Volume 15 Issue 2 Benefits | biologics

Continue Reading →

Volume 15 Issue 2

Advancements of Gene Editing Technologies(CRISPR/Cas9)

An Introduction to Gene Editing – CRISPR-Cas9 The dynamic promise of gene editing for humans is the ability to precisely manipulate the sequence of the cell genom...

3 July 2023 Volume 15 Issue 2 Advancements | cell

Continue Reading →

Volume 15 Issue 2

Gene Edited iPSCs May Find a Place in Allogeneic Therapies

An Introduction to Pluripotency Pluripotent: adjective; capable of giving rise to many different cell types. This is the hallmark characteristic of the induced pl...

3 July 2023 Volume 15 Issue 2 allogeneic | cell

Continue Reading →

Volume 15 Issue 2

Accessibility in Rare Disease Paediatric Clinical Trials

Approximately 360 million people globally are living with a rare disease. Over half of these are children. Many of the diseases are life-threatening and only 5% have...

3 July 2023 Volume 15 Issue 2 caregivers | children

Continue Reading →